Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus Infections

Explore clinical trials studying Respiratory Syncytial Virus Infections. Study availability and eligibility vary by location and protocol.

146 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus Infections trial results

Completed

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

NCT01968083

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • University of California, UC San Diego CRS La Jolla, California, United States
  • Miller Children's Hospital at Long Beach Memorial Medical Center Long Beach, California, United States
  • The Children's Hospital University of Colorado Denver, Colorado, United States
  • Rush Univ. Cook County Hosp. Chicago NICHD CRS Chicago, Illinois, United States
View Trial Details
Completed

A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection

NCT03332459

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Fukuyama City Hospital Fukuyama, Japan
  • Hirosaki National Hospital Hirosaki, Japan
  • National Hospital Organization Niigata National Hospital Niigata, Japan
  • National Hospital Organization Beppu Medical Center Ōita, Japan
View Trial Details
Completed

RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

NCT02873286

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Paradigm Research Redding, California, United States
  • Optimal Research San Diego, California, United States
  • Compass Research The Villages, Florida, United States
  • Meridian Clinical Research Savannah, Georgia, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.

NCT02878330

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Anaheim, California, United States
  • Research Site Anaheim, California, United States
  • Research Site Downey, California, United States
View all 161 locations
View Trial Details

Related conditions